摘要
目的:系统评价八段锦对伴发抑郁症状患者的有效性。方法:通过检索中英文数据库,纳入与八段锦干预抑郁症状相关的随机对照试验(RCT)。进行文献筛选、资料提取、质量和偏倚风险评价后,采用RevMan 5.1软件进行Meta分析,比较治疗组与对照组在抑郁自评量表(SDS)评分及汉密尔顿抑郁量表(HAMD)评分方面的差异,并根据干预的疗程进行亚组分析。结果:共纳入9个RCT研究(治疗组357例,对照组352例),Meta分析结果显示治疗组SDS评分改善优于对照组(P <0.05),亚组分析结果显示治疗组干预1个月、3个月、6个月结果均优于对照组(P <0.05)。治疗组HAMD评分改善总体优于对照组(P <0.05),干预40天、42天、84天结果均优于对照组(P <0.05)。结论:对伴发抑郁症状患者,联合开展八段锦干预,不论干预周期长短均可有效改善患者症状,促进患者康复。
Objective:To evaluate the effectiveness of Baduanjin in patients with depressive symptoms.Methods:A randomized controlled trial(RCT)related to Baduanjin intervention for depressive symptoms was included by searching the Chinese and English databases.Performed Meta-analysis by using RevMan 5.1 software after literature screening,data extraction,quality and bias risk assessment.Compared the differences of the scores of self-rating depression scale(SDS)and the Hamilton depression scale(HAMD)between the treatment group and the control group.Performed subgroup analysis according to the course of intervention.Results:A total of 9 RCT studies were included(357 cases in the treatment group and352 cases in the control group).The meta-analysis showed that the SDS score of the treatment group was better than that of the control group(P<0.05);the subgroup analysis showed that the results of intervention at 1 month,3 months,and 6 months were better than those in the control group(P<0.05).The improvement of HAMD score in the treatment group was better than that in the control group(P<0.05);the results of 40,42 and 84 days of intervention were better than those in the control group(P<0.05).Conclusion:For patients with depressive symptoms,the combined application of Baduanjin intervention can effectively improve the symptoms and promote the recovery regardless of the length of the intervention period.
作者
邱定荣
林小丽
赵经营
陈笑银
QIU Dingrong;LIN Xiaoli;ZHAO Jingying;CHEN Xiaoyin
出处
《新中医》
CAS
2019年第6期51-54,共4页
New Chinese Medicine
基金
2016年广东省中医院中医药科学技术研究专项(YN2016HL01)
